106 related articles for article (PubMed ID: 8321021)
1. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
Ludwig L; Janssen JW; Schulz AS; Bartram CR
Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
[TBL] [Abstract][Full Text] [Related]
2. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Preudhomme C; Vachee A; Quesnel B; Wattel E; Cosson A; Fenaux P
Leukemia; 1993 Jul; 7(7):1071. PubMed ID: 8321023
[No Abstract] [Full Text] [Related]
3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
4. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia.
Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T
Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976
[TBL] [Abstract][Full Text] [Related]
5. Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient.
Ludwig L; Janssen JW; Bartram CR
Leukemia; 1995 May; 9(5):922-4. PubMed ID: 7769857
[TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression.
Kaneko H; Horiike S; Nakai H; Ueda Y; Nakao M; Hirakawa K; Yokota S; Taniwaki M; Misawa S; Kashima K
Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322
[TBL] [Abstract][Full Text] [Related]
7. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia.
Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P
Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944
[TBL] [Abstract][Full Text] [Related]
8. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
[TBL] [Abstract][Full Text] [Related]
11. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
13. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
14. c-fms point mutations in acute myeloid leukemia: fact or fiction?
Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
[TBL] [Abstract][Full Text] [Related]
15. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
[TBL] [Abstract][Full Text] [Related]
16. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1).
Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S
Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886
[TBL] [Abstract][Full Text] [Related]
17. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
Abernathy CR; Colman SD; Kousseff BG; Wallace MR
Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
[TBL] [Abstract][Full Text] [Related]
18. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations.
Christiansen DH; Desta F; Andersen MK; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2007 Jun; 46(6):517-21. PubMed ID: 17330262
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of neurofibromatosis type 1 mutations.
Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
